arise by selection acting over time on populations consisting of large numbers of variants. The idea that variation is not noise but is rather the substrate for the emergence of biological form and function provides an underlying theme that is central to and defining of what I have called the sciences of recognition. These include evolution itself, embryology (particularly morphogenesis), immunology, and the neurobiology of complex brains. In all these arenas recognition at molecular, cellular, and organismal levels occurs through selective processes. In each case, the substrate is biochemical while the higher order rules are governed by variation and selection.
I propose to tell a few anecdotes from my early experiences, particularly those that led to molecular immunology. I recount them to point out that scientists can have blind spots and occasionally forget the lesson that one must consider all the levels of organization that emerge from selective events.
Antigen Recognition and Molecular Immunology
In 1958, I was fascinated by the specificity of antigen recognition by antibodies.
At the same time I was frustrated as a chemist by the heterogeneity of the γ-globulin fractions containing these antibodies (2) . Free boundary electrophoresis by Arne Tiselius and Elvin Kabat (3) revealed a stark contrast between the distribution of net charge of these proteins as compared to that of other serum proteins. I was driven by the hope of resolving this heterogeneity and had the dream, naïve as it was at the time, that by doing the primary structure of antibody molecules, the basis of their specificity would be revealed. In 1959, after cleaving disulfide bonds in so-called 7S γ-globulins, I decided to examine their behavior by analytical centrifugation. (From now on I will refer to these molecules as immunoglobulins, the modern term). I was both startled and elated to find that the molecules dissociated into subunits after reduction and alkylation in a denaturing solvent (4) . This provided grounds for my first hope: that one of the polypeptide chains might be small enough to work out its amino acid sequence. At that time, Sanger (5) had completed the sequencing of insulin (molecular weight 6000) and Stein and Moore (6) were sequencing ribonuclease which had a molecular weight of about 13,700. My hopes were certainly naïve, for the 7S immunoglobulin had a molecular weight of 150,000.
In any event, the problem of heterogeneity remained to be solved. In the early 60's,two ideas that were derived from my medical experience proved critical. The first was that perhaps the proteins found in large amounts in the serum of patients with the cancer of plasma cells called multiple myeloma, might in fact be pure immunoglobulins. Unlike immunoglobulins from normal persons, they were each homogeneous and each differed from the others in net charge. It was easy to show that these myeloma proteins could be cleaved into polypeptide chains of the same size as that of their supposed normal counterparts.
In some patients with myeloma, the urine contains a smaller protein that is also homogeneous,but with a remarkable property: When heated, the urine becomes cloudy in much the same fashion as urine containing albumen. But on continued heating the urine becomes clear. This so-called Bence Jones protein was the second protein discovered after Liebig first described albumen. Given my hypothesis about myelomas, the thought arose that perhaps Bence Jones protein was one of the chains of the myeloma protein spilled into the urine because of its relatively low molecular weight (about 22,000). If this were the case, the dream of sequencing an immunoglobulin might be realized.
But what about specificity? There was no evidence that myeloma proteins were synthesized as a result of immunization by specific antigens. It was much more likely that the process of neoplasia occurred in a single plasma cell, causing it to overproduce a myeloma protein. This was consistent with the idea (not at all popular at the time) that each myeloma was a single member of a vast preexisting population of immunoglobulin antibodies. These notions were consistent with the proposals of Niels Jerne (7) and Macfarlane Burnet (8) that the immune response was a selectional, not an instructional, process. That is, the various immunoglobulins were synthesized prior to antigen exposure and made up a repertoire of variant proteins; immunization by an antigen stimulated division of those cells with immunoglobulins that happened to bind that antigen and thus make more antibodies-Burnet's process of clonal selection. The most popular theory at the time was, by contrast, an instructional one, the clearest expression of which was that of Linus Pauling (9): The single long chain of the antibody was assumed to fold around the immunizing antigen, providing a complementary fit which after dissociation of the antigen could then bind molecules of similar shape by weak forces. This theory by a great chemist was straightforward and widely accepted but later turned out to be incorrect.
Learning from Theorists
And now, two anecdotes. The first considers events that followed the demonstration with my student, Joseph Gally (10) Gally and I were pursuing our work on myelomas, convinced that selectionist ideas were correct, we received a visit by Burnet in our small basement lab. He asked "What are you doing?".I replied, "We are working on the chemistry of antibodies and hope to work out their detailed structure. Like you, we are selectionists".
He replied, "You are wasting your time. Chemistry only makes things more complicated. I don't even call them antibodies. The term recognizers is good enough."
I replied, "But Sir, if we don't do the chemistry to show how many variants there are in the antibody repertoire, we won't know if the theory is sound". He said, "Mathematics can make things even worse. Don't worry, young man, my theory is correct".
Well, it turned out that it was correct. Reflecting on the gifts and contributions of Pauling,the chemist, and Burnet, the biologist, I could see hints of blind spots that sooner or later we must all confront. Pauling looked only at the chemical level. He ignored the fact that the body did not produce antibodies to its own antigens, a fact difficult to account for simply by instructional folding. This cellular phenomenon of immune tolerance was a key element in Burnet's thinking. For his part, Burnet was insufficiently respectful of the biochemical rules, the syntax that would ultimately reveal in detail the origins of antibody diversity and specificity.
The Dénouement: Domains and Somatic Variation
The analysis of these rules was to emerge largely from the work of our laboratory and that of Rodney Porter (13, 14) (18) which revealed these processes in fact to be the origin of diversity.
Immunology was revealed as a science of recognition having special mechanisms of somatic selection that themselves had evolved by natural selection.
Cell-Cell Recognition and Morphogenesis
By 1970, I concluded that the work in immunology had "scratched my itch" and showing that signals from the so-called organizer could set up the embryonic axis.
Work by Holtfreter (22) showed that dissociated cells from the different germ layers would sort out to re-form these layers. Despite these and other remarkable achievements of the embryologists, a global explanation of how the genetics and the mechanics worked together to yield form was lacking.
Even during this early work, it was clear that form arose from some combination of the primary processes of development: cell division, cell migration, cell death, cell adhesion, and embryonic induction. It seemed to me in the mid-1970's that cell adhesion was a central candidate process in establishing and maintaining animal form. But to link it to genetics required that it be mediated by specific protein molecules and not, as the then prevailing view had it, by weak forces at the cell membrane (23) . I was stimulated to reach this conclusion by the description of mice that showed abnormal morphogenesis of the cerebellar cortex as a result of point mutations (24) .
Given my immunological experience, it was not surprising that I attempted to raise antibodies that, when present in cell cultures, would prevent cell-cell adhesion.
My colleagues and I decided to use retinae from embryonic chicks as a source of cells, on the assumption that we would need large numbers of cells. It turned out, in fact, that we used up thousands of fertilized eggs. This effort, which began in earnest in 1974, finally yielded a specific antibody, allowing us to isolate the neural cell adhesion molecule (NCAM), the first cell-cell adhesion molecule to be purified and characterized (25, 26) . NCAM is a most unusual intrinsic membrane protein which is expressed at a very early stage of vertebrate development. It is later expressed on all neural tissues and some other tissues in specific patterns that, when perturbed by antibodies, result in distortions of form during embryonic development. At about the same time, we began to isolate CAMS that, unlike NCAM, required calcium for their cell-cell binding activity (27) . These calcium-dependent CAMS were also studied extensively by Takeichi and coworkers (28) who named them cadherins.
As is usually the case in such periods of discovery, there was an explosion of work on the differential binding of these CAMS, their location at different sites during development, their down-regulation during cell movement, and their effects on cell division. A key emphasis in my laboratory was on structure and binding. Early on, we found that NCAM had an unusual negatively charged sugar, polysialic acid, which changed in amount and form during development (29) . We were also able to show that NCAM binding was homophilic-NCAM on one cell bound NCAM on an apposing cell. High amounts of polysialic acid tended to weaken this binding during cell migration which, in some locations, was also favored by down-regulation of the CAM at the cell surface. It seemed to me that, to make sense of the data in these apparently disparate fields, one needed a global theory of brain action that was based on the biology of recognition events, rather than on abstract computation. Unfortunately, in freeing itself from behaviorism, cognitive psychology was based on a computer model, a machine model of the mind that tended to ignore the evolutionary facts (38) . Driven by my experience in embryology, immunology, and population thinking, I felt that the problem of recognition of environmental and bodily changes by the brain was likely to be solved by a selectionist theory, not by one based on logical instruction. influenced by value systems. According to the theory, reentry across these connections and those to the thalamus allowed enormously heightened discriminations among different signals to arise from the dynamic activity of the thalamocortical system of a brain so equipped. The phenomenal experiences entailed by these neural activities are these discriminations, the so-called qualia discussed by philosophers. By being able flexibly to plan their responses, animals possessing these abilities would have an adaptive advantage over those unable to make such discriminations (46) .
Selection upon Selection and the Sciences of Recognition
The long trail from antibodies to conscious brain events has reinforced my conviction that evolution, immunology, embryology, and neurobiology are all sciences of recognition whose mechanics follow selectional principles. Natural selection is, of course, the governing process, selecting biochemical mechanisms of those systems that are able to deal with individual recognition events in somatic time.
All selectional systems follow three principles. There must be a generator of diversity, a polling process of the diverse repertoires that ensue, and a means of differential amplification of the selected variants. However, each selectional system employs a different set of mechanisms. In evolution we see mutation, competition, and differential reproduction. In immunology, we have somatic mutation and recombination, antigenic modification and circulation, and clonal expansion of selected lymphocytes. In development, we have variation in local collectives with epigenetic selection of primary processes resulting in form that is subject to natural selection .In neurobiology we add to these morphogenetic principles the polar properties of neurons firing together and wiring together to create an enormous network of functional connectivity within an overall anatomy. This anatomy is characteristic of a species, but necessarily shows enormous individual variation. Within this network, synaptic strengths are selected in a value-dependent fashion by behavior. Synchronization of these selective events occurs via the process of reentry which acts in time periods of milliseconds.
In all cases, although the syntactic rules are given by the biochemistry, the operation of these rules is constrained by the behavior of the higher order organization they help to create. Achieving a deeper understanding of these systems, a project that I like to call completing Darwin's program, will continue to rest on further exploration of the details of their biochemical interactions.
Understanding: The Ultimate Recognition
In reflecting on the tale just told, I realize that I have left out much and that what appears to be a pattern in retrospect was not all that apparent in prospect. I have not mentioned all the colleagues that made it possible to realize the insights I have mentioned here. Claude Bernard, the doyen of homeostasis, once said "Art is I, Science is We." We begin our research as artists, but must combine our efforts in a community.
In the long reach of scientific truth which we pursue together, we end as a paragraph.
That is as it should be.
After 50 years in research, it may be of some use if I make a few remarks about change and organizational style. I have the impression that when I began my work, a central driving force of biochemical research was, above all, the desire to understand.
In the enormous technological explosion that has occurred in the last decade, that desire is still there but it seems to be muted. We live now in an age of quick publication, fashionable journals, multi-author papers, and the predominance of rather bureaucratic or risk-free criteria for the awarding of grants. We seem to be living in a period dominated by data collecting, a period of molecular natural history.
What has emerged from this effort is a picture of enormous biochemical complexity (47) , one only dimly foretold in previous times. On reflection, this is perhaps not surprising, given the fact that not all evolution occurs by natural selection and the fact that correlative variation can occur during selection. The more we see, the more the creatures of our effort seem to grow hair. I suspect that it will take some time before we develop a theory that will allow us to understand the intricate parallel biochemical networks in the eukaryotic cell. As is obvious from my account, I believe that, in this enterprise, thinking is the most important and challenging part of the biochemist's task. Taking this position involves a risk that many large organizations of science are not willing to support. I would hope that that some measures are put in place to support scientific monasteries, institutes that are small (less than 50 scientists), freely funded to avoid burdening the young with grant bureaucracy, and diverse across specialties but not too diverse (48) . In founding The Neurosciences Institute, I have tried to realize these conditions. The diversity that would be created if there were more such organizations, each arranged around a different focus, might help to encourage young scientists to transform the present mass of data into a general picture that will ultimately relate biological complexity to evolution in a satisfying way. Understanding --the ultimate recognition --remains the name of the game.
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